BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1184 related articles for article (PubMed ID: 33405402)

  • 1. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
    Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
    Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
    Haraszti S; Sendil S; Jensen N
    Am J Case Rep; 2020 Oct; 21():e926901. PubMed ID: 33097683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test.
    Stingeni L; Francisci D; Bianchi L; Hansel K; Tramontana M; Di Candilo F; Mannarino MR; Pirro M
    Contact Dermatitis; 2021 Sep; 85(3):366-368. PubMed ID: 33834491
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis associated with clindamycin in a patient with Hailey-Hailey disease.
    Casillas AC; Barragan VA; Alhalaseh Y; Modi MB; Lake E; Speiser JJ
    J Cutan Pathol; 2023 Oct; 50(10):864-868. PubMed ID: 37430411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
    Lee HY; Chou D; Pang SM; Thirumoorthy T
    Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts.
    Speeckaert MM; Speeckaert R; Lambert J; Brochez L
    Eur J Dermatol; 2010; 20(4):425-33. PubMed ID: 20542841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.
    Bailey K; McKee D; Wismer J; Shear N
    J Cutan Med Surg; 2013; 17(6):414-8. PubMed ID: 24138979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin-induced acute generalized exanthematous pustulosis: A case report.
    Aiempanakit K; Apinantriyo B
    Medicine (Baltimore); 2020 May; 99(21):e20389. PubMed ID: 32481338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
    Hadavand MA; Kaffenberger B; Cartron AM; Trinidad JCL
    J Am Acad Dermatol; 2022 Sep; 87(3):632-639. PubMed ID: 32926975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management.
    Parisi R; Shah H; Navarini AA; Muehleisen B; Ziv M; Shear NH; Dodiuk-Gad RP
    Am J Clin Dermatol; 2023 Jul; 24(4):557-575. PubMed ID: 37156992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis (AGEP): A review and update.
    Szatkowski J; Schwartz RA
    J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, diagnosis and management of cephalosporin-induced acute generalized exanthematous pustulosis.
    Lei H; Deng H; Liu X; Li Z; Wang C
    J Clin Pharm Ther; 2022 Dec; 47(12):2008-2013. PubMed ID: 35909299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis.
    Sussman M; Napodano A; Huang S; Are A; Hsu S; Motaparthi K
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
    Enos T; Jeong HS; Vandergriff T; Jacobe HT; Chong BF
    Dermatol Ther; 2020 Nov; 33(6):e13834. PubMed ID: 32542893
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
    Pearson KC; Morrell DS; Runge SR; Jolly P
    Cutis; 2016 Mar; 97(3):212-6. PubMed ID: 27023083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis induced by piroxicam: a case report.
    Cherif Y; Jallouli M; Mseddi M; Turki H; Bahloul Z
    Indian J Pharmacol; 2014; 46(2):232-3. PubMed ID: 24741202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
    Schwartz RA; Janniger CK
    Dermatol Ther; 2020 May; 33(3):e13380. PubMed ID: 32253799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute generalized exanthematous pustulosis.
    Sidoroff A
    Chem Immunol Allergy; 2012; 97():139-48. PubMed ID: 22613859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis: report of five cases and systematic review of clinical and histopathological findings.
    Vassallo C; Derlino F; Brazzelli V; D'Ospina RD; Borroni G
    G Ital Dermatol Venereol; 2014 Jun; 149(3):281-90. PubMed ID: 24819755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.